Should we be performing more combined hematopoietic stem cell plus solid organ transplants?

被引:25
作者
Chiang, KY
Lazarus, HM
机构
[1] Childrens Healthcare Atlanta, Div Pediat Hematol Oncol Blood & Marrow Transplan, Atlanta, GA 30322 USA
[2] Cleveland State Univ, Dept Med, Ireland Canc Ctr, Cleveland, OH 44115 USA
关键词
bone marrow transplant; solid organ transplant;
D O I
10.1038/sj.bmt.1703952
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Both bone marrow and solid organ transplants (SOTS) can be life saving for a wide variety of diseases. We reviewed the literature and summarized the experiences of dual transplants. In total, 37 patients received a SOT for organ failure after a previous hematopoietic stem cell transplant. In all, 12 subjects received SOTS followed by a bone marrow transplant, while three patients received simultaneous SOTS and bone marrow transplants. Of these 52 patients, 37 were alive at the time of the original report at follow-up times ranging from 3 months to 8 years. A special registry for data collection may prove helpful for obtaining long-term follow-up data and providing outcome information that may improve future patient survival.
引用
收藏
页码:633 / 642
页数:10
相关论文
共 66 条
[1]  
BARONCIANI D, 1993, BONE MARROW TRANSPL, V12, P91
[2]   THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION [J].
BEARMAN, SI .
BLOOD, 1995, 85 (11) :3005-3020
[3]   EMERGENCY LIVER-TRANSPLANTATION FOR FULMINANT-HEPATITIS [J].
BISMUTH, H ;
SAMUEL, D ;
GUGENHEIM, J ;
CASTAING, D ;
BERNUAU, J ;
RUEFF, B ;
BENHAMOU, JP .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :337-341
[4]  
Bühler L, 1999, TRANSPLANTATION, V67, P630
[5]   Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease [J].
Bühler, LH ;
Spitzer, TR ;
Sykes, M ;
Sachs, DH ;
Delmonico, FL ;
Tolkoff-Rubin, N ;
Saidman, SL ;
Sackstein, R ;
McAfee, S ;
Dey, B ;
Colby, C ;
Cosimi, AB .
TRANSPLANTATION, 2002, 74 (10) :1405-1409
[6]   Related donor liner transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation [J].
Bunin, N ;
Leahey, A ;
Dunn, S .
TRANSPLANTATION, 1996, 61 (04) :664-666
[7]   Renal transplantation for end-stage renal disease following bone marrow transplantation: A report of six cases, with and without immunosuppression [J].
Butcher, JA ;
Hariharan, S ;
Adams, MB ;
Johnson, CP ;
Roza, AM ;
Cohen, EP .
CLINICAL TRANSPLANTATION, 1999, 13 (04) :330-335
[8]   LUNG TRANSPLANTATION IN A PATIENT WITH A PRIOR BONE-MARROW TRANSPLANT [J].
CALHOON, JH ;
LEVINE, S ;
ANZUETO, A ;
BRYAN, CL ;
TRINKLE, JK .
CHEST, 1992, 102 (03) :948-948
[9]   Six-year clinical effect of donor bone marrow infusions in renal transplant patients [J].
Ciancio, G ;
Miller, J ;
Garcia-Morales, RO ;
Carreno, M ;
Burke, GW ;
Roth, D ;
Kupin, W ;
Tzakis, AG ;
Ricordi, C ;
Rosen, A ;
Fuller, L ;
Esquenazi, V .
TRANSPLANTATION, 2001, 71 (07) :827-835
[10]   Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients [J].
Corry, RJ ;
Chakrabarti, PK ;
Shapiro, R ;
Rao, AS ;
Dvorchik, I ;
Jordan, ML ;
Scantlebury, VP ;
Vivas, CA ;
Fung, JJ ;
Starzl, TE .
ANNALS OF SURGERY, 1999, 230 (03) :372-379